Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1974-09-20
1977-04-12
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
260112R, 260113, 260115, C07G 704
Patent
active
040176053
ABSTRACT:
N-acylated orgotein, although possessing substantially less SODase activity than the native protein, possesses antiinflammatory activity comparable to that of orgotein.
REFERENCES:
patent: 3579495 (1971-05-01), Huber
patent: 3637640 (1972-01-01), Huber
patent: 3758682 (1973-09-01), Huber et al.
patent: 3764711 (1973-10-01), Melnychyn et al.
Chemical Reactions of Polymers, Fettes, 1965, pp. 371-384.
Huber Wolfgang
Saifer Mark G.
Williams Lewis D.
Diagnostic Data, Inc.
Schain Howard E.
LandOfFree
Acylated orgotein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylated orgotein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylated orgotein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1281788